Shares of Insmed jumped Tuesday after the biopharmaceutical firm reported positive results from a Phase 2 trial for its treatment of pulmonary arterial hypertension.

Zac Gunn was diagnosed with pulmonary hypertension, a rare and extremely serious condition that affects the heart and lungs, in 2019 and put up a brave fight with his illness until the end.

Still, the answer rattled me enough that I called my doctor the next morning. After a quick physical exam, they ordered a ...

Now, new research has revealed the top prescription hotspots for erectile dysfunction – and it shows that men in the East Riding of Yorkshire are coming out on top. Here, 3.5% of the local population ...

A 68-year-old woman was referred for investigation of pulmonary artery hypertension. Right heart catheterisation was performed and the tip of the catheter was positioned in the right middle lobe ...

Long-term exposure to particulate matter in patients with pulmonary arterial hypertension increases risk for lung transplantation or death.

There is increased risk for pulmonary hypertension in patients with both atrial fibrillation and incident venous thromboembolism.

The Cardiac Centre at Al Qassimi Hospital, operated by Emirates Health Services (EHS), has become the first facility in the ...

Panelists discuss how riociguat targets the nitric oxide pathway and is approved for both Group 1 PAH and Group 4 chronic thromboembolic pulmonary hypertension, with specific patient selection ...

Liquidia shipped its first FDA-approved product, Yutrepia for pulmonary hypertension in June entering market worth several ...